iLIRKO mice displayed hyperinsulinemia and increased beta cell mass, suggesting a liver–pancreas endocrine axis in which IGF-1 functions as a liver derived growth factor to promote compensatory pancreatic islet hyperplasia through IRA [13]. The gene discussed is IGF1; the disease is hyperinsulinism.